Ignite Creation Date:
2025-12-24 @ 9:28 PM
Ignite Modification Date:
2025-12-31 @ 2:36 AM
Study NCT ID:
NCT01083732
Status:
COMPLETED
Last Update Posted:
2016-12-28
First Post:
2010-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-03
Start Date Type:
None
Primary Completion Date:
2016-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-02
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-08
First Submit QC Date:
None
Study First Post Date:
2010-03-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-08-17
Results First Submit QC Date:
None
Results First Post Date:
2016-12-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-02
Last Update Post Date:
2016-12-28
Last Update Post Date Type:
ESTIMATED